IP Library Assignment 054122/0895
Patent Assignment
Reel/Frame 054122/0895

Change of Name

Recorded: 2020-10-19 Pages: 2
Assignor
VEGENICS LIMITED
Executed: 2010-11-19
Assignee
VEGENICS PTY LTD
SUITE 0403, LEVEL 4, 650 CHAPEL STREET, SOUTH YARRA, 3141, AUSTRALIA
Covered Property (1)
Methods for Treating Neoplastic Disease Characterized by Vascular Endothelial Growth Factor D Expression, for Screening for Neoplastic Disease or Metastatic Risk, and for Maintaining Vascularization of Tissue
Patent: 7,534,572 →
Application: 10/627,631 →
Publication: US 2005/0202015
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 13, 2007
From: LUDWIG INSTITUTE FOR CANCER RESEARCH
To: VEGENICS LIMITED
Reel/Frame 020234/0786 →
Assignment of Assignor's Interest Oct 19, 2020
From: ACHEN, MARC; STACKER, STEVEN
To: LUDWIG INSTITUTE FOR CANCER RESEARCH
Reel/Frame 054099/0805 →